Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 8 Xanthines.

Slides:



Advertisements
Similar presentations
Role of anticholinergic therapy in COPD Adil Al Sulami Medical Resident KAUH.
Advertisements

Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 32 Bronchodilator Drugs and the Treatment of Asthma.
CHAPTER 37 Bronchodilators and Other Respiratory Drugs
1 Copyright © 2012, 2008, 2002, 1998, 1994, 1989, 1984, 1978 by Mosby, Inc., an affiliate of Elsevier Inc. Reminder:  QUIZ NEXT WEEK ON:  Anti-infectives,
CNS STIMULANTS SAMUEL AGUAZIM. What is the definition of a CNS stimulant? A CNS stimulant is a drug that increases motor activity, causes excitement and.
CNS Stimulants 1. Analeptics stimulate autonomic system (respiratory and circulation) 2. Methylxanthines (caffeine, theobromate and theophylline) 3. Central.
Management of COPD & Asthma Melissa Brittle & Jessica Macaro.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 11 Antianxiety Agents.
Drugs For Treating Asthma
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 10 Local Anesthetics.
Respiratory drugs -Surag Khadka. Learning outcomes Classes of drugs MoA of the following Beta-2 agonists Anti-cholinergics Leukotriene antagonists Methylxanthines.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 18 Autocoids and Antihistamines.
Cardiac drugs Cardiac glycoside Cardiac glycosides are the most effective drugs for treatment of C.H.F. Digitoxins are plant alkaloids. They increase myocardial.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 76 Drugs for Asthma.
Chapter 5 Autonomic Drugs.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 25 Drug Interactions.
Alpha-Adrenergic Blockers
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Anticholinergic (Parasympatholytic) Bronchodilators.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 16 Anticonvulsants.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 22 Heart Failure Drugs.
Chapter 32 Airway Pharmacology
Bronchodilators ( 支气管扩张药 ) Huifang Tang ( 汤慧芳 ) Department of Pharmacology Zhejiang university, school of Medicine
Adrenergic antagonist sympatholytic
DRUGS USED IN ASTHMA. Asthma is an inflammatory disease of the airways characterized by episodes of acute bronchoconstriction causing shortness of breath,
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 3 Adverse Reactions.
Drug Therapy Heart Failure by Pat Woodbery, MSN, ARNP.
Methylxanthines RC 195.
1 Drug Treatment of heart failure. Prof. Azza El-Medani Prof. Abdulrahman Almotrefi.
 most commonly consumed psychoactive drug in the world ◦ in US – consumed by 80% adult population ◦ found in coffee, tea, cola, chocolate and cocoa ◦
Drugs used in asthma By S.Bohlooli, PhD. Asthma therapy Short term relievers Bronchodilators Long term controllers Anti-inflammatory agent Leukorienes.
Bronchodilators Lilley Pharmacology Text: Chapter 35
PROF. AZZA El-Medany Department of Pharmacology OBJECTIVES At the end of lectures the students should Describe the different classes of drugs used for.
Drugs for Heart Failure Identify the major risk factors that accelerate the progression to heart failure. 2.Relate how the classic symptoms associated.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 21 Positive Inotropic Drugs.
Caffeine Dagmar Smětalová Tamara Franková. The "Discovery" of Coffee Legend has it that coffee was "discovered" around 850 AD in upper Egypt by a goat.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 36 Bronchodilators and Other Respiratory Drugs.
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 6 Adrenergic (Sympathomimetic) Bronchodilators.
Bipyridines :(Amrinone,Milrinone ) only available in parenteral form. Half-life 3-6hrs. Excreted in urine.
Chapter 33 Agents Affecting the Autonomic Nervous System.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 17 Adrenergic Drugs.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Cholinergic Drugs.
Chapter 9 Respiratory System Drugs Copyright © 2011 Delmar, Cengage Learning.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 20 Cholinergic Drugs.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 16 Central Nervous System Stimulants and Related.
PHARMACOLOGY OF RESPIRATORY DRUGS Susanne Young May 04’
Copyright © 2012, 2008, 2002, 1998, 1994, 1989, 1984, 1978 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 7 Anticholinergic (Parasympatholytic)
(Theophylline) Toxicity د/ عبد المنعم جودة مدبولى
Chapter 2.6. Central Nervous System Stimulants 中枢神经兴奋药.
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 21 Diuretic Agents.
Overview of Receptors and Drugs
Course in the Ward Oxygen saturation was 85-88% despite oxygen per mask at 5-6 lpm. She was nebulized with salbutamol and post-nebulization parameters.
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 2 Principles of Drug Action.
Theophylline in broncial asthma. By:Heba Othman Essam El-Din Pharm –D4(2009).
Bronchodilators and Other Respiratory Agents
Clinical pharmacology of drugs acting on the respiratory organs function.
β2 Agonists Albuterol and other inhaled short-acting selective β2 agonists are indicated for treatment of intermittent episodes of bronchospasm and are.
Heart Failure  Dfinition:  Clinical features  Underlying causes of HF include Arteriosclerotic heart disease, MI, hypertensive heart disease, valvular.
Drugs Used to Treat Heart Failure
Drugs in obstructive lung diseases
Drugs affecting the respiratory system
Pharmacology - Xanthines
Plants Used for Respiratory Problems - II
Hawler Medical University Department of Pharmaceutical chemistry
Drug Therapy Heart Failure
Pharmacological actions of cathecholamines
METHYL XANTHINES.
Chapter 32 Airway Pharmacology
METHYL XANTHINES 20/01/2012.
Chapter 5 Autonomic Drugs.
Drugs used in asthma.
Presentation transcript:

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 8 Xanthines

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Clinical Indications for Use of Xanthines  Use in asthma  Theophylline: maintenance therapy (step 2 or higher) of mild, persistent asthma  Side effects and narrow therapeutic index may make it a poor choice versus other agents

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Clinical Indications for Use of Xanthines (cont’d)  Use in COPD  Theophylline: recommended by GOLD as alternative to β 2 agonist and anticholinergics  Use in apnea of prematurity  First-line treatment  Theophylline most often used, but caffeine citrate may be better choice (safer, higher therapeutic index)

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Specific Xanthine Agents  a.k.a. methylxanthines  Found as alkaloids in plant species  Theophylline  Tea leaves  Theobromine  Cocoa seeds or beans  Caffeine  Coffee beans and kola nuts  Cocoa seeds or beans  Tea leaves

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. General Pharmacological Properties  Effects on humans  CNS stimulation  Cardiac muscle stimulation  Diuresis  Bronchial, uterine, and vascular smooth muscle relaxation Theophylline is generally classified as a bronchodilator Theophylline is generally classified as a bronchodilator  Peripheral and coronary vasodilation  Cerebral vasoconstriction Used in headache remedies Used in headache remedies

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. General Pharmacological Properties (cont’d)  Structure-activity relations  Theophylline Methyl attachments at N-1 and N-3 enhance bronchodilation/increase side effects Methyl attachments at N-1 and N-3 enhance bronchodilation/increase side effects  Caffeine Additional methyl group at N-7 decreases bronchodilation Additional methyl group at N-7 decreases bronchodilation  Dyphylline Derivative of theophylline with methyl attachment at N-7 that weakens bronchodilation Derivative of theophylline with methyl attachment at N-7 that weakens bronchodilation  Enprofylline Not available in United States Not available in United States Potent bronchodilator Potent bronchodilator Large substitution at N-3 position Large substitution at N-3 position

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. General Pharmacological Properties (cont’d)  Proposed theories of activity  Exact mechanism of action unknown Smooth muscle relaxation via inhibition of phosphodiesterase (?) Smooth muscle relaxation via inhibition of phosphodiesterase (?) Antagonism of adenosine (?) Antagonism of adenosine (?) Catecholamine release (?) Catecholamine release (?)

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Titrating Theophylline Doses  Individuals metabolize theophylline at different rates  Equivalent doses of theophylline salts  Anhydrous theophylline = 100% theophylline  Salts of theophylline not pure by weight

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Titrating Theophylline Doses (cont’d)  Serum levels of theophylline  <5 μg/ml: No effects seen  10 to 20 μg/ml: Therapeutic range  >20 μg/ml: Nausea  >30 μg/ml: Cardiac arrhythmias  40 to 45 μg/ml: Seizures  Asthma  5 to 15 μg/ml  COPD  10 to 12 μg/ml

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Titrating Theophylline Doses (cont’d)  Dosage schedules  Used to titrate drug levels  Rapid theophyllization: 5 mg/kg lean body weight oral loading dose of anhydrous theophylline 5 mg/kg lean body weight oral loading dose of anhydrous theophylline Each 0.5 mg/kg = 1 μg/ml serum level Each 0.5 mg/kg = 1 μg/ml serum level  Slow titration: 16 mg/kg/24 hr or 400 mg/24 hr (whichever is less) 16 mg/kg/24 hr or 400 mg/24 hr (whichever is less)

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Titrating Theophylline Doses (cont’d)  Methods of titration:  Clinical reaction of patient  Serum drug levels  1 to 2 hours after administration (immediate release)  5 to 9 hours after administration (sustained release)

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Theophylline Toxicity and Side Effects  Narrow therapeutic margin  Distressing side effects may occur at therapeutic levels  Common side effects:  Gastric upset Not recommended in patients with peptic ulcer or acute gastritis Not recommended in patients with peptic ulcer or acute gastritis  Headache  Anxiety  Diuresis

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Factors Affecting Theophylline Activity  Conditions affecting liver/kidneys  Interactions with other drugs  Conditions that increase theophylline levels:  Viral hepatitis  Left ventricular failure  Condition that decreases theophylline levels:  Smoking  Additive effect:  β Agonists

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Clinical Uses  Asthma  Use debated  Only after other relievers and controllers have failed  COPD  If ipratropium bromide and β 2 agonist fail to provide control

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Nonbronchodilating Effects of Theophylline  Increase in force of respiratory muscle contractility  Increase in respiratory muscle endurance  Increase in ventilatory drive  Cardiovascular effects  Increased cardiac output  Decreased pulmonary vascular resistance  Antiinflammatory effects

Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Use in Apnea of Prematurity  Xanthines are the first-line choice when nonpharmacological methods unsuccessful  Caffeine citrate preferred over theophylline  Loading dose of 20 mg/kg  Daily maintenance dose of 5 mg/kg